CHRONIC HEPATITIS B INFECTION
Clinical trials for CHRONIC HEPATITIS B INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hepatitis b pill shows promise in Head-to-Head trial
Disease control Recruiting nowThis study tests a new oral medication, ALG-000184, against an existing drug (tenofovir) for chronic hepatitis B. About 200 adults with untreated hepatitis B will take one pill daily for 48 weeks. The goal is to see if the new drug can suppress the virus better or as well as the …
Matched conditions: CHRONIC HEPATITIS B INFECTION
Phase: PHASE2 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated May 17, 2026 10:36 UTC
-
New study checks kidney impact on hepatitis b drug
Knowledge-focused Recruiting nowThis study looks at how a single dose of the experimental drug pevifoscorvir sodium (ALG-000184) is processed by the body in people with different levels of kidney function. About 30 adults with chronic hepatitis B and either severe, mild, moderate, or normal kidney function will…
Matched conditions: CHRONIC HEPATITIS B INFECTION
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC